Showing 1 - 4 results of 4 for search 'Timothy S. Oh', query time: 0.03s
Refine Results
-
1
-
2
Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study by Natalie S. Grover, Kaitlin Annunzio, Marcus Watkins, Pallawi Torka, Reem Karmali, Andrea Anampa-Guzmán, Timothy S. Oh, Heather Reves, Montreh Tavakkoli, Emily Hansinger, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Geoffrey Shouse, Adam J. Olszewski, Narendranath Epperla
Published 2024-10-01Get full text
Article -
3
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy by Reid Shaw, James J. Yoon, Hannah Johnston, Marta B. Davidson, Alexa J. Siddon, Rory M. Shallis, Evan C. Chen, Madelyn Burkart, Timothy S. Oh, Sunil G. Iyer, Ellen Madarang, Chandrasekar Muthiah, Joshua Kassner, Raajit K. Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin Abaza, Jacqueline S. Garcia, Vikas Gupta, Kristen M. Pettit, Olatoyosi Odenike, Anand A. Patel
Published 2025-05-01Get full text
Article -
4
Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms by Leah A. Goldberg, James J. Yoon, Hannah Johnston, Marta B. Davidson, Alexa Siddon, Rory M. Shallis, Evan C. Chen, Madelyn Burkart, Timothy S. Oh, Sunil G. Iyer, Ellen Madarang, Chandrasekar Muthiah, Joshua Kassner, Raajit K. Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin Abaza, Jacqueline S. Garcia, Vikas Gupta, Kristen M. Pettit, Olatoyosi Odenike, John F. Cursio, Anand A. Patel
Published 2025-05-01Get full text
Article